CIMIT blog

BrightCove Media

As you know, CIMITblog has been playing things pretty low key for the last month. This is because we are in the midst of switching over all of our media to brand new servers thanks to BrightCove.

So far, only our most recent post on Healthcare Delivery Reform is coming to you from the new BrightCove servers, but the rest of the media is in the process of being transferred and will automatically (tirelessly by hand on our side) transition to the new services over the next couple of weeks. Rest assured there will be no further interruptions.

BrightCove is helping us to enable full screen functionality, drastically improved screen resolution, provide users with embed codes and social sharing capabilities, and in a few weeks videos will be available on the iphone/mobile devices. Oh, and finally... It's cheaper for us. 

So, thanks for hanging around, we hope you enjoy the new services that will apply to all new publications of media, and soon for old publications. 

Best,

Mike

CIMITblog is a publication of the Center for Integration of Medicine and Innovative Technology (CIMIT)

#FDASM - The FDA's Public Hearings on Social Media

19 NOVEMBER 2009, BOSTON - Zen Chu (Accelerated Medical Ventures and CIMIT's Innovation Grand Rounds) recently testified at the FDA's public hearings on Social Media and Internet (#FDASM). The FDA is grappling with a number of questions centered around regulation and accountability for Healthcare and the use of Social Media, with implications for direct-to-consumer advertising, patient safety, adverse event reporting, disease management, and new technology innovation.

The FDA thought it wise to bring together qualified experts from a wide range of areas to give testimony. Streaming video available for the next 20 days: http://www.fdasm.com/

I thought Zen had an interesting testimony, perspective and has shared it with us.

Zen Chu: My purpose was to lend an innovation and new ventures perspective to the FDA panel:

• FDA should lend clarity to regulations and exercise restraint to enable new technologies and services to engage patients
• FDA needs to distinguish between ads and messages delivered to benefit wellness, compliance, adherence
• FDA must hire more expertise in new media and technology to understand and provide more timely guidelines
• A New Media & Technology Advisory Board, comprise of both industry, academia and patient advocates should be created to advise FDA

Zen Chu Healthcare Innovation FDA Testimony DDMAC Public Hearings on Internet & Social Media #FDASM

View more documents from MedicalVentures.

Socialnomics & Healthcare

18 NOVEMBER 2009, BOSTON - Nice old piece on Socialnomics, which has been seen a lot by now, but with the FDA Public Hearings on Social Media (#FDASM) I think it is appropriate to bring it back and refresh us. The Social Media Revolution...

CIMIT blog is a publication of the Center for Integration of Medicine and Innovative Technology